Author

V. Bondu

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Biochemistry· 1 Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 4 Organism:human· 3 Assay:flow cytometry· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Assay:fluorescence / live-cell microscopy· 1

Frequent Co-Authors

T. Buranda· 3 shared A. Wandinger-Ness· 2 shared L. Shevy· 2 shared P. Simons· 2 shared S. Young· 2 shared A. J. Luna· 1 shared A. Kell· 1 shared B. Fetrow· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

T. Buranda

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Inhibition of Cellular MEK/ERK Signaling Suppresses Murine Papillomavirus Type 1 Replicative Activities and Promotes Tumor Regression

A. J. Luna, J. M. Young, R. T. Sterk, V. Bondu, F. A. Schultz, D. F. Kusewitt, H. Kang, M. A. Ozbun

This paper shows that MEK1/2 inhibitors reduce MmuPV1 replication and promote tumor regression in mice, suggesting MEK1/2 as a therapeutic target for papillomavirus diseases.

bioRxiv · Mar 14, 2023Cancer Biology

G-Trap Assay I: Small GTPases as sensitive immune response biomarkers for active bacteremia

R. Clark, V. Bondu, P. C. Simons, L. Shevy, E. F. Castillo, S. Young, N. Kanagy, A. Wandinger-Ness, T. Howdieshell, T. Buranda

This study uses a novel G-Trap assay to detect GTPase activation in trauma patients, showing it correlates with infection-induced immune activation and antibiotic treatment effects.

bioRxiv · Jun 9, 2022 · PreprintImmunology

G-Trap Assay II: Characterization of blood Leukocyte Functionality differentiates immune activation and immune suppression in bacteremia patient samples

V. Bondu, P. Simons, L. Shevy, A. Wandinger-Ness, S. Young, T. Buranda

The paper measures Rac1*GTP in blood leukocytes from sepsis patients and controls to differentiate immune activation from suppression, identifying elevated levels in infected patients.

bioRxiv · Jun 9, 2022 · PreprintImmunology

Rapid and Effective Inactivation of SARS-CoV-2 by a Cationic Conjugated Oligomer with Visible Light: Studies of Antiviral Activity in Solutions and on Supports

K. Kaya, M. I. Khalil, B. Fetrow, H. Fritz, P. Jagadesan, V. Bondu, L. Ista, E. Y. Chi, D. Whitten, K. S. Schanze

This study demonstrates a cationic conjugated oligomer that inactivates SARS-CoV-2 and E. coli under visible light in solution and on coated materials.

bioRxiv · Oct 18, 2021Biochemistry

Integrin activation is an essential component of SARS-CoV-2 infection

P. Simons, D. Rinaldi, V. Bondu, A. Kell, S. Bradfute, D. Lidke, T. Buranda

This study investigates the role of integrin activation in SARS-CoV-2 infection using UV-inactivated virus and integrin antagonists.

bioRxiv · Jul 20, 2021Cell Biology